HEСъфинансиране2025–2029

VIDA · VHIO International postDoctoral programme for translAtional research

„Хоризонт Европа“ — Действия „Мария Склодовска-Кюри“

Период
2025-01-01 → 2029-12-31
Финансиране от ЕС
1 719 360 €
Участници
17
Схема
HORIZON-TMA-MSCA-Cofund-P

Линиите свързват координатора с партньорите.

Накратко на български

Персонализираната медицина в онкологията търси нови начини за диагностика и лечение на рака. Това помага за подобряване на превенцията, ранното откриване и грижите за здравето на пациентите в Европа.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Цел на проекта

The proposed “VHIO International postDoctoral programme for translAtional research” (VIDA) aims at enabling outstanding junior scientists of all nationalities to develop a competitive research project at VHIO, an international reference center for personalized medicine in oncology that thanks to its pioneering model of multidisciplinary and translational research is among the leading comprehensive cancer centers in Europe.VIDA aims to nurture excellent postdoctoral fellows to advance research, personalised medicine in oncology and patient health care in Europe. Following a fair, merit-based and inclusive recruitment process, the programme will hire 12 postdoctoral researchers to carry out a research project that will benefit from a stimulating and creative environment, career development and mentoring schemes, and access to high-end technologies and facilities. Importantly, they will benefit from a tailored advanced training programme on the latest technologies, open science, gender and innovation, and from a specific mentoring scheme, with the opportunity to build valuable national and international networks with different actors in academia, hospitals, industry, editors and universities. VIDA counts on the support and collaboration of 15 associated partner organisations. The trained fellows will be equipped with skills and knowledge to tackle relevant clinical and research questions, and ultimately pursue new approaches to diagnose and treat oncology diseases. Overall, the VIDA Programme will provide fellows skills and competences for developing a successful career in both the academic and non-academic sector and VHIO is a unique institute to bring them the possibility of contributing to improve prevention, early diagnosis, monitoring and treatment of cancer patients; key intervention areas of the Horizon Europe Mission on Cancer.

Оригинален текст от CORDIS (на английски).

Участници

  • FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON (VHIO) · BarcelonaКоординаторИспания
  • DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG · HeidelbergГермания
  • Departament de Recerca i Universitats_Generalitat de Catalunya · BarcelonaИспания
  • FUNDACIO D'ESTUDIS I RECERCA ONCOLOGICA (FERO) · BarcelonaИспания
  • FUNDACIO BARCELONABETA BRAIN RESEARCH CENTER · BarcelonaИспания
  • FUNDACIO CENTRE DE REGULACIO GENOMICA · BarcelonaИспания
  • FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER · BarcelonaИспания
  • FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA · BARCELONAИспания
  • FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA · BarcelonaИспания
  • FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA) · BarcelonaИспания
  • FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA · BarcelonaИспания
  • FUNDACION UNIVERSITARIA SAN PABLO-CEU · MadridИспания
  • INSTITUT GUSTAVE ROUSSY · VillejuifФранция
  • KAROLINSKA INSTITUTET · STOCKHOLMШвеция
  • OMNISCOPE LIMITED · MOSTAМалта
  • PRISMA ASOCIACION PARA LA DIVERSIDAD AFECTIVO-SEXUAL Y DE GENERO EN CIENCIA TECNOLOGIA E INNOVACION · PAMPLONAИспания
  • SPRINGER NATURE LIMITED · Basingstoke HantsОбединеното кралство

Връзки

Данни: CORDIS, © Европейски съюз